Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Characterization of Extrapulmonary Fibrosis in the Bleomycin Minipump Model
EF 2023-24
Résumé
Fibrosis is an abnormal tissue repair process involving excessive scarring and tissue destruction that can occur in any organ. Fibrosis is the hallmark of Systemic Sclerosis (SSc), an autoimmune disease characterized by multi-organ fibrotic damage. Therapeutic options for SSc are limited and often do not address the systemic involvement of the disease, prompting further research with the potential for improved treatments. One approach is to study animal models that re-create disease features of SSc. The systemic delivery of bleomycin, a drug causing oxidative damage leading to fibrosis, is used as a model for SSc and produces SSc-like skin and lung fibrosis. While this model has been proposed to induce multi-organ fibrosis, the involvement of the kidneys, liver, heart and gut remains unclear. One aim of this project is to extend the study of this model to other major organs and explore organ-specific protective mechanisms shaping susceptibility and resistance to fibrosis. Previous studies show that oxidative damage is linked to fibrosis development, with an internal antioxidant defence system limiting fibrotic damage. Therefore, the proposed research explores the hypothesis that the bleomycin response is associated with oxidative damage and has tissue-specific features. In addition to assessing the role of the antioxidant system, immune responses to oxidative damage affecting fibrotic damage in different tissues will be studied. Identifying the key immune and antioxidant factors in tissue-specific responses to bleomycin-mediated oxidative damage will broadly contribute to our understanding of organ-specific vulnerability in the broader context of age-related and chronic diseases, and is the foundation for future research on anti-fibrotic therapies.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506134
Name
Johri Rishabh
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterization of Extrapulmonary Fibrosis in the Bleomycin Minipump Model
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Autoimmune Disease; Bleomycin; Fibrosis; Inflammation; Murine Model; Oxidative Stress; Reactive Oxygen Species; Systemic Sclerosis
Abstract
Fibrosis is an abnormal tissue repair process involving excessive scarring and tissue destruction that can occur in any organ. Fibrosis is the hallmark of Systemic Sclerosis (SSc), an autoimmune disease characterized by multi-organ fibrotic damage. Therapeutic options for SSc are limited and often do not address the systemic involvement of the disease, prompting further research with the potential for improved treatments. One approach is to study animal models that re-create disease features of SSc. The systemic delivery of bleomycin, a drug causing oxidative damage leading to fibrosis, is used as a model for SSc and produces SSc-like skin and lung fibrosis. While this model has been proposed to induce multi-organ fibrosis, the involvement of the kidneys, liver, heart and gut remains unclear. One aim of this project is to extend the study of this model to other major organs and explore organ-specific protective mechanisms shaping susceptibility and resistance to fibrosis. Previous studies show that oxidative damage is linked to fibrosis development, with an internal antioxidant defence system limiting fibrotic damage. Therefore, the proposed research explores the hypothesis that the bleomycin response is associated with oxidative damage and has tissue-specific features. In addition to assessing the role of the antioxidant system, immune responses to oxidative damage affecting fibrotic damage in different tissues will be studied. Identifying the key immune and antioxidant factors in tissue-specific responses to bleomycin-mediated oxidative damage will broadly contribute to our understanding of organ-specific vulnerability in the broader context of age-related and chronic diseases, and is the foundation for future research on anti-fibrotic therapies.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Johri, Rishabh
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~